AASLD 2025 Nov 7-11 Wash DC
 
Jordi Verheyen1, Hannah Vanrusselt1, Tse-I Lin1, Zhili Wang2, Selena Lin2, Ying-Hsiu Su2, Stéphane Plaisance3, Jin Hong4, Julian Symons4, Lawrence Blatt4, Andreas Jekle4 and Yannick Debing1 1 Aligos Belgium BV, Leuven, Belgium; 2 JBS Science, Doylestown, PA; 3 VIB Nucleomics Core, Leuven, Belgium; 4 Aligos Therapeutics, Inc., South San Francisco, CA